We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$95.6M
Cap. Flow
+$79.9M
Cap. Flow %
4.52%
Top 10 Hldgs %
10.21%
Holding
1,825
New
561
Increased
356
Reduced
388
Closed
510

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$21.7M
2
HLF icon
Herbalife
HLF
+$20.4M
3
TXRH icon
Texas Roadhouse
TXRH
+$18M
4
BKNG icon
Booking.com
BKNG
+$17.7M
5
LOW icon
Lowe's Companies
LOW
+$15.5M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$14.3M
2
UPS icon
United Parcel Service
UPS
+$10.8M
3
LULU icon
lululemon athletica
LULU
+$9.52M
4
AMZN icon
Amazon
AMZN
+$8.2M
5
GILD icon
Gilead Sciences
GILD
+$7.98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.14%
2 Technology 14.57%
3 Healthcare 11.17%
4 Industrials 9.82%
5 Financials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNT
1776
DELISTED
UNIT Corporation
UNT
-16,219
Closed -$231K
RARX
1777
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-45,823
Closed -$1.03M
WAAS
1778
DELISTED
AquaVenture Holdings Limited
WAAS
-17,283
Closed -$334K
ZAYO
1779
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-119,398
Closed -$3.39M
FOMX
1780
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
-10,701
Closed -$40K
AVEO
1781
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-10,366
Closed -$85K
PIR
1782
DELISTED
Pier 1 Imports, Inc.
PIR
-9,194
Closed -$140K
MDR
1783
DELISTED
McDermott International
MDR
-263,432
Closed -$1.96M
ARQL
1784
DELISTED
Arqule Inc
ARQL
-47,544
Closed -$228K
CARB
1785
DELISTED
Carbonite Inc
CARB
-9,773
Closed -$242K
VSI
1786
DELISTED
Vitamin Shoppe Inc.
VSI
-46,353
Closed -$326K
SEMG
1787
DELISTED
SEMGROUP CORPORATION
SEMG
-31,210
Closed -$460K
NVTR
1788
DELISTED
Nuvectra Corporation Common Stock
NVTR
-12,286
Closed -$135K
DOVA
1789
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-21,422
Closed -$190K
GHDX
1790
DELISTED
Genomic Health, Inc.
GHDX
-16,678
Closed -$1.17M
RTEC
1791
DELISTED
Rudolph Technologies Inc
RTEC
-16,188
Closed -$369K
ISCA
1792
DELISTED
International Speedway Corp
ISCA
-9,727
Closed -$424K
SFLY
1793
DELISTED
Shutterfly, Inc.
SFLY
-135,415
Closed -$5.5M
CRAY
1794
DELISTED
Cray, Inc.
CRAY
-32,116
Closed -$837K
WAGE
1795
DELISTED
WageWorks, Inc.
WAGE
-33,183
Closed -$1.25M
PES
1796
DELISTED
Pioneer Energy Services Corp.
PES
-33,807
Closed -$60K
HIVE
1797
DELISTED
Aerohive Networks
HIVE
-29,862
Closed -$135K
ARRY
1798
DELISTED
Array Biopharma Inc
ARRY
-23,986
Closed -$585K
LEXEA
1799
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-21,936
Closed -$939K
PETX
1800
DELISTED
Aratana Therapeutics, Inc.
PETX
-53,224
Closed -$192K

Similar funds

A.R.T. Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, A.R.T. Advisors held 1,825 positions worth $1.77B, up 5.7% from $1.67B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

A.R.T. Advisors deployed $79.9M of net new capital in Q2 2019, opening 561 new positions and adding to 356 existing holdings. Its largest new stake was Nike: 257,500 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was lululemon athletica, an estimated $9.52M trimmed.

  • A.R.T. Advisors's largest Q2 2019 buy was Nike: 257,500 shares worth $21.6M.
  • A.R.T. Advisors added most to Herbalife in Q2 2019, an estimated $20.4M increase.
  • A.R.T. Advisors's biggest Q2 2019 reduction was lululemon athletica, cutting an estimated $9.52M.
  • A.R.T. Advisors fully exited Starbucks in Q2 2019, selling an estimated $14.3M.
  • A.R.T. Advisors's ten largest holdings make up 10% of its $1.77B portfolio in Q2 2019.
  • A.R.T. Advisors opened 561 new positions and closed 510 in Q2 2019.
  • A.R.T. Advisors's portfolio value rose 5.7% quarter-over-quarter to $1.77B.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.